Last reviewed · How we verify
NCT05541263: MindRest
Mindful Network Dynamics Regulation Under Stress
NA trial testing Mindfulness Based Stress Reduction in Stress in 75 participants. Terminated before completion.
1 March 2024
Quick facts
| Lead sponsor | Radboud University Medical Center |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 75 |
| Start date | 1 March 2021 |
| Primary completion | 1 March 2024 |
| Estimated completion | 1 May 2025 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Mindfulness Based Stress Reduction
Conditions studied
- Stress — all drugs for Stress →
Sponsor
Radboud University Medical Center
Who can join
18 and older, any sex, with Stress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to assess the effectiveness of Mindfulness Based Stress reduction to reduce perceived stress in a highly stressed student population, while concurrently investigating neural mechanisms of the intervention. The investigators will perform a randomized, wait-list controlled trial assessing clinical and neurocognitive outcomes as well as measures of daily life stress reactivity.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Study protocol for a randomised controlled trial investigating the effects of Mindfulness Based Stress Reduction on stress regulation and associated neurocognitive mechanisms in stressed university students: the MindRest study.
Kogias N, Geurts DEM, Krause F, Speckens AEM, et al · · 2023 · cited 3× · PMID 37393359 · DOI 10.1186/s40359-023-01220-4 -
Study protocol for a randomised controlled trial investigating the effects of Mindfulness Based Stress Reduction on stress regulation and associated neurocognitive mechanisms in stressed university students: The MindRest study
Kogias N, Geurts DEM, Krause F, Speckens AEM, et al · · 2023 · DOI 10.1101/2023.05.24.23290218
Verify or expand the search:
- PubMed search for NCT05541263
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mindfulness Based Stress Reduction
Trials testing the same drug.
- NCT04980612 — Development and Feasibility of Mindfulness Based Pain Reduction · NA · active not recruiting
- NCT05100537 — Effect of Mindfulness Based Stress Reduction (MBSR) Programme for Reducing the Stress Level of Nursing Student · NA · completed
- NCT04016415 — Decreasing Stress in Diabetes · NA · completed
- NCT04625777 — Selah Trial of Stress Interventions for Clergy: Mindfulness Based Stress Reduction, Daily Examen, and Stress Inoculation · NA · completed
- NCT03998462 — Mindfulness Based Stress Reduction for Parkinson's Disease: A Longitudinal Study · NA · completed
Other recruiting trials for Stress
Currently open trials in the same condition.
- NCT07485790 — The Effects of Yoga on Pregnant Women · NA · recruiting
- NCT07469527 — Effects of Feel Free® Classic Tonic on Stress and Pharmacokinetics in Healthy Adults · NA · recruiting
- NCT07387107 — Decreasing Stress Via Virtual Reality and Binaural Beats in Non-Clinical Adults · NA · recruiting
- NCT07240792 — Development of a College Student-Delivered Cognitive-Behavioral Therapy (CBT) Intervention for Rural High School Student · NA · recruiting
- NCT07518056 — Relationships Between Nomophobia Levels and Perceived Stress, Body Image and Food Addiction Among University Students · recruiting
Other Radboud University Medical Center trials
Trials by the same sponsor.
- NCT07485569 — Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial · Phase 1 · not yet recruiting
- NCT07514325 — MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer · NA · not yet recruiting
- NCT07530263 — Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA) · Phase 1 · not yet recruiting
- NCT07532577 — Intranasal Insulin to Prevent Intensive Care Unit Delirium · Phase 2, PHASE3 · not yet recruiting
- NCT07504172 — Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05541263 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Radboud University Medical Center
- Last refreshed: 22 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05541263.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing